NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.

Int J Cancer · 2022 · PMC9299709 · PMID 34716584

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In all cases a P ‐value of .05 and below was considered significant (*), P < .01(**), P < .001 (***) and P < .0001 (****) as highly significant. 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.